There are two forms of iron circulation in the seminiferous tubules (SFT). First, extracellular iron enters the Sertoli cells of the testis through the TF-TFR1 pathway, which is the main route of exogenous iron intake in Sertoli cells. As with other iron metabolic pathways, exogenous TBI is transported to Sertoli cells, and TBI is transported to endosomes. The FPN in Sertoli cells is responsible for iron release into the SFT gap. Sertoli cells synthesize and secrete CP, which oxidizes ferrous iron in the SFT gap to TF-bound iron. Iron output to the basement membrane of the SFT also requires TF, which is synthesized in the endoplasmic reticulum of Sertoli cells. Fe3+ binds to newly synthesized TF and is uptaken by spermatogenic cells into the circulation of iron. The second type of iron is derived from transport among spermatogenic cells at all levels. Iron is absorbed by spermatogonia and preleptotene spermatocytes through the TF-TFR1 pathway, and it is continuously transferred to round spermatids via different mechanisms. Eventually, round spermatids release some of the iron, which circulates to the apical compartment of Sertoli cells, and the rest of the iron is carried away by elongated spermatids. In addition, mitochondria in mature spermatozoa are phagocytosed by Sertoli cells in the form of residual bodies, and Sertoli cells store the iron in ferritin and return it to the iron cycle of primary spermatocytes, thereby completing the autonomous cycle of iron transport in the SFT. The loss of iron during spermatogenesis is compensated for by the absorption of exogenous iron. In addition to iron metabolism disorders, xCT/GPX4 system disturbances, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress may increase the susceptibility to ferroptosis in the testis. Some transcription factors, such as NRF2, regulate genes related to ferroptosis under oxidative stress. ACSL4 acyl-CoA synthetase long-chain family member 4, ALOXs Arachidonate lipoxygenases, CP ceruloplasmin, Fe-S iron-sulfur clusters, FPN Ferroportin, FTH ferritin heavy chain, FTL ferritin light chain, GPX4 glutathione peroxidase 4, GPX4mito mitochondrial GPX4, GSH glutathione, HO1 heme oxygenase 1, LIP labile iron pool, LPCAT3 lysophosphatidylcholine acyltransferase 3, FtMt mitochondrial ferritin, mTOR mammalian target of rapamycin, NRF2 nuclear factor erythroid 2-related factor 2, NCOA4 nuclear receptor coactivator 4, NQO1 quinone oxidoreductase 1, PUFA polyunsaturated fatty acid, ROS reactive oxygen species, TF transferrin, TFR1 transferrin receptor 1.